↓ Skip to main content

The Use of Pharmacological Retromer Chaperones in Alzheimer's Disease and other Endosomal-related Disorders

Overview of attention for article published in Neurotherapeutics, January 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
2 patents

Readers on

mendeley
90 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
The Use of Pharmacological Retromer Chaperones in Alzheimer's Disease and other Endosomal-related Disorders
Published in
Neurotherapeutics, January 2015
DOI 10.1007/s13311-014-0321-y
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 90 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
India 2 2%
Netherlands 1 1%
Unknown 87 97%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 19 21%
Student > Ph. D. Student 13 14%
Student > Bachelor 12 13%
Student > Master 12 13%
Other 7 8%
Other 9 10%
Unknown 18 20%
Readers by discipline
Readers by discipline Count As %
Agricultural and Biological Sciences 21 23%
Biochemistry, Genetics and Molecular Biology 18 20%
Neuroscience 11 12%
Medicine and Dentistry 6 7%
Chemistry 4 4%
Other 9 10%
Unknown 21 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 November 2022.
All research outputs
#6,086,043
of 27,773,453 outputs
Outputs from Neurotherapeutics
#649
of 1,396 outputs
Outputs of similar age
#74,718
of 367,938 outputs
Outputs of similar age from Neurotherapeutics
#11
of 20 outputs
Altmetric has tracked 27,773,453 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 1,396 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.7. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 367,938 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.